In skeletal muscle, excitation-contraction (EC) coupling and retrograde signaling are thought to result from direct interactions between the ryanodine receptor (RyR1) and the α 1 subunit of the dihydropyridine receptor (α 1S ). Previous work has shown that the s53 region of α 1S (residues 720-765 in the II-III loop) and regions R10 (1635-2636) and R9 (2659-3720) of RyR1 are involved in this signaling. Using the yeast two-hybrid system, we here report an interaction between s53 and the sR16 region of RyR1 (1837-2168, within R10), whereas no interaction was seen using upstream residues of the α 1S II-III loop (s31, 666-709). The specificity of the s53-sR16 interaction was tested by using fragments of the cardiac RyR (RyR2) and DHPR (α 1C ) that correspond to sR16 and s53, respectively. No interaction was observed for sR16 x c53 (α 1C 850-897), but weak interaction was occasionally observed for s53 x cR16 (RyR2 1817-2142). To test the functional significance of the s53 x sR16 interaction, we expressed in dyspedic myotubes a chimeric RyR ("chimeraR16") in which sR16 was substituted for the corresponding region of RyR2. ChimeraR16 was found to mediate weak skeletal-type EC coupling. To test the necessity of sR16 sequence for coupling, we used "chimeraR16-rev" in which sR16 and a small upstream region of RyR1 were replaced by RyR2 sequence.
INTRODUCTION
In muscle cells, excitation-contraction (EC) coupling is the process by which depolarization of the plasma membrane produces the large transient release of Ca 2+ from the sarcoplasmic reticulum (SR) which, in turn, triggers contraction. Dihydropyridine receptors (DHPRs), L-type Ca 2+ channels in the plasmalemma, serve as the voltage sensors for EC coupling (1) and activate ryanodine receptors (RyRs), intracellular Ca 2+ release channels in the SR membrane (2, 3) . In cardiac muscle, entry of Ca 2+ through the DHPR activates the RyR (4).
In skeletal muscle, however, entry of Ca 2+ through the DHPR is not required for EC coupling (5) .
Instead, a voltage-dependent conformational change in the II-III loop of the skeletal muscle DHPR α 1 subunit (α 1S ) has been hypothesized to allosterically activate the skeletal muscle ryanodine receptor, RyR1. In addition to this orthograde EC coupling signal, which is transmitted from α 1S to RyR1, there is also a retrograde signal whereby the presence of RyR1 increases Ca 2+ current density produced by α 1S (6) .
Because the skeletal muscle isoforms of DHPRs and RyRs are required for skeletal-type EC coupling and retrograde signaling, functional expression of skeletal-cardiac chimeras of both proteins has been used to determine regions of α 1S and RyR1 that participate in bi-directional signaling. Expression of chimeric DHPR α 1 subunits in dysgenic muscle (which lacks α 1S ) has revealed that α 1S residues 720-765 in the intracellular loop between domains II and III (the II-III loop) are necessary for bi-directional signaling in dysgenic myotubes (7, 8) . Similarly, expression of chimeric RyRs in dyspedic myotubes (which lack RyR1) has shown that regions R9 (residues 2659-3720) and R10 (residues 1635-2636) of RyR1 participate in signaling interactions with α 1S (9) .
Despite these functional data, there is little evidence as to whether signaling between α 1S
and RyR1 results from direct contact between the two proteins. A number of studies have addressed this question in vitro. Direct binding in protein affinity columns has identified interactions between peptides corresponding to the II-III (10) and III-IV (11) loops of α 1S and a peptide corresponding to residues 951-1112 of RyR1 (but not to the equivalent RyR2 residues).
However, replacement of this region of RyR1 with the equivalent RyR2 residues in chimeric RyRs does not interfere with bi-directional interactions in functional assays (9) . The responses of isolated RyRs to peptides corresponding to specific regions of DHPRs have also been used to study interactions between α 1S and RyR1. In particular, residues 671-690 of α 1S ("peptide A"), or subdivisions of this region, have been found to activate RyR1 (12) (13) (14) (15) (16) (17) (18) . However, skeletal sequence in this region is not required for EC coupling by intact DHPRs expressed in dysgenic myotubes (7, 8, 19, 20) . The divergent results of functional and biochemical studies are difficult to reconcile and may indicate that there are multiple sites of contact, individually of low affinity, that mediate signaling between α 1S and RyR1.
In this paper, we have attempted to identify domains of α 1S and RyR1 that participate in both direct binding and functional coupling between the two proteins. Using the yeast two-hybrid system, we have observed a weak interaction between the s53 region of the α 1S II-III loop (residues 720-765) and the sR16 region of RyR1 (residues 1837-2168 within R10). The functional significance of this interaction was tested using chimeric RyRs expressed in dyspedic myotubes. When substituted into a RyR2 backbone, region sR16 was sufficient to confer weak skeletal-type EC coupling ("chimeraR16"). The mirror chimera ("chimeraR16-rev"), in which sR16 and an upstream region of RyR1 were replaced by RyR2 sequence, was used to test whether skeletal sequence in the R16 region was required for bi-directional signaling.
ChimeraR16-rev did not differ significantly from RyR1 in its coupling with α 1S . These results suggest that R16 is one site of contact between RyR1 and DHPRs that participates in EC coupling, and that other such sites likely exist. 
EXPERIMENTAL PROCEDURES

Molecular biology and yeast two-hybrid assays
For yeast two-hybrid interaction tests, portions of the rabbit skeletal muscle ryanodine receptor (RyR1; (21)) or cardiac muscle ryanodine receptor (RyR2; (22) ) were inserted in-frame into the GAL4 activation domain plasmid pGAD424 (Clontech, Palo Alto, CA) by means of restriction sites added to the ends of the fragments generated by polymerase chain reaction (PCR). Similarly, dihydropyridine receptor α 1S (23), α 1C (24, 25) , or β subunit (26) fragments were inserted in-frame into the GAL4 binding domain plasmid, pGBT9 (Clontech). Two fragments (sR16 and s53) were expressed and assayed for yeast two-hybrid interaction in both pGAD424 and pGBT9. All inserts generated by PCR were confirmed by automated DNA sequencing (Macromolecular Resources, Fort Collins, CO). For yeast two-hybrid clones, the template used and amino acids expressed (in parentheses) and primer pairs used were as follows:
R10A (RyR1 1633- The mammalian expression plasmid "chimeraR16" was constructed by substituting nucleotides 5508-6462 of RyR1 for nucleotides 5449-6354 of RyR2 using EcoR1 and XhoI restriction sites. This produced a chimeric ryanodine receptor that is RyR2 in sequence except for replacement of residues 1817-2118 by the residues 1837-2154 of RyR1. The plasmid encoding "chimeraR16-rev" was constructed by ligating a PCR fragment comprised of RyR2 nucleotides 4912-6358 into the AgeI (4936) and XhoI (6466) sites in pCIneoRyR1 (6) . This resulted in a chimeric ryanodine receptor that had RyR1 sequence except for replacement of residues 1645-2154 by RyR2 residues 1637-2118.
Expression of ryanodine receptors in dyspedic myotubes
Primary cultures of myotubes were prepared from newborn dyspedic mice as previously described (27) . Approximately 1 week after plating, plasmids carrying cDNA for RyR1, RyR2, 
RESULTS
Domain sR16 of RyR1 binds to domain s53 of α 1S
To test the hypothesis that skeletal-type EC coupling results from a direct physical interaction between the II-III loop of α 1S and a discrete domain of RyR1, we used the yeast twohybrid system to test for interaction between regions of the two proteins that were previously identified in functional studies. In yeast, we expressed two regions of the α 1S II-III loop as fusion proteins with the binding domain of the GAL4 transcription factor: s53 (α 1S residues 719-767) and s31 (α 1S 666-709). We also expressed, as fusion proteins with the activation domain of GAL4, subdivisions of the R9 and R10 regions of RyR1, which were previously identified as important for signaling interactions with α 1S (9) . These subdivisions were approximately 300 residues in length, the maximum size that can be tested using the two-hybrid system. The skeletal constructs are indicated in Figure 1 and are designated with the prefix "s." To determine the specificity of interactions between RyR1 and α 1S , we also tested corresponding regions of α 1C
and RyR2 for interactions; the cardiac constructs are designated with the prefix "c." c53 (α 1C residues 850-897) corresponds to s53, and cR16 (RyR2 1817-2142) corresponds to sR16. between the test fragments) were never observed for yeast co-transformed with s31 and any of the RyR constructs. This absence of colonies suggests that the s31 region does not interact with the RyR domains tested, and is consistent with experiments using expression in myotubes which demonstrated that this region of α 1S is not critical for signaling interactions with RyR1 (7, 19, 20) . In contrast, colonies were consistently observed for yeast co-transformed with sR16 and s53
(n = 15), although their appearance required incubation of the plates for 7-10 days. This indicates that the interaction is quite weak, because colonies appeared within 2-4 days (data not shown) for yeast co-transformed with "αID" and "βID," which are responsible for the strong binding of the β subunit to α 1S (31) . The lacZ reporter gene (which encodes β-galactosidase)
yielded similar results: a blue reaction product, indicating expression of β-galactosidase, was observed for yeast containing s53 and sR16 in four of four separate transformations. To ensure that the yeast two-hybrid positive result for the s53 x sR16 interaction was independent of the GAL4 segments of the fusion proteins, we constructed the mirror clones with s53 inserted into the GAL4 activation domain vector and sR16 inserted into the GAL4 binding domain vector. An interaction was observed in three of four transformations performed with this pair of clones. The specificity of the interaction between s53 and sR16 was also tested by replacing them with c53 and cR16, respectively. Colonies were not observed for c53 when co-transformed with any of the RyR1 segments (n = 5), but were occasionally seen on test plates streaked with yeast bearing cR16 and s53 (5 of 14 transformations). Thus, s53 is also able to interact with the cR16 region of RyR2, albeit less efficiently than with the sR16 region of RyR1.
ChimeraR16 mediates weak skeletal-type EC coupling
To determine whether there was a physiological correlate of the yeast interaction between s53 and sR16, we constructed "chimeraR16," a chimeric skeletal-cardiac ryanodine receptor.
ChimeraR16 had RyR2 sequence except for replacement of residues 1817-2118 by the corresponding region of RyR1 (1837-2154). Thus, chimeraR16 contained all but the final 14 residues (2155-2168) of sR16, which were omitted for cloning reasons and which, because RyR1 and RyR2 are highly conserved in this region, resulted in only three amino acid changes (E2157A, C2158S and I2167S, using RyR1 numbering). RyR1, chimeraR16, or RyR2 were expressed in dyspedic myotubes (which lack endogenous RyR1 currents which had a "U-shaped" voltage-dependence (Fig. 2C ). This behavior is consistent with skeletal-type EC coupling, which is independent of the entry of extracellular Ca 2+ (5) . The voltage-dependence of the transients for chimeraR16 suggested that they were partially dependent on Ca 2+ entry (since they were maximal at about the same potential at which inward current peaked), but that they also contained a component of skeletal-type coupling since the transients were still appreciable at +80 mV (Fig. 2B, inset) and persisted after addition of Cd As a separate assay of the ability of chimeraR16 to participate in skeletal-type EC coupling, we determined whether electrical stimulation could elicit contractions in the absence of Ca 2+ entry through α 1S . Electrically evoked contractions were observed in almost 80% of dyspedic myotubes expressing RyR1, whereas none were observed in cells expressing RyR2 ( 
Lack of retrograde signaling by ChimeraR16
To determine the ability of chimeraR16 to enhance Ca 2+ current via α 1S (retrograde signaling, (6)), we measured Ca 2+ current density in dyspedic myotubes expressing RyR1, chimeraR16, or RyR2. As shown in Figure 2C , Ca 2+ current density in myotubes expressing chimeraR16 was much smaller than in cells expressing RyR1 and only a little larger than in cells expressing RyR2, which was previously shown (6) not to produce retrograde enhancement of Ca 2+ current. On average, the maximal peak Ca 2+ current density in cells expressing chimeraR16 from that in cells expressing RyR2 (3.11 ± 0.56 pA/pF, n = 18). Thus, chimeraR16 appears unable to carry out retrograde signaling to α 1S .
The R16 region is not required for bi-directional signaling with α 1S
The experiments described above indicated that the R16 region of RyR1 is sufficient for weak EC coupling. To determine if this region is necessary for signaling, we constructed "chimeraR16-rev," in which RyR2 residues 1637-2118 replaced residues 1645-2154 within RyR1. Thus, chimeraR16-rev lacks the RyR1 sequence (1837-2154) present in chimeraR16 as well adjacent RyR1 sequence region towards the amino terminal. If the sR16 region were necessary for bi-directional signaling, one would expect signaling to be lacking in cells expressing chimeraR16-rev. In fact, both Ca 2+ transients and Ca 2+ currents in dyspedic myotubes expressing chimeraR16-rev were similar to those in cells expressing RyR1 (Fig. 4) . Moreover, chimeraR16-rev did not differ from RyR1 in its ability to mediate skeletal-type EC coupling, as indicated by electrically evoked contractions in the absence of Ca 2 + entry through α 1S .
Specifically, 31 of 38 myotubes expressing chimeraR16-rev contracted in response to electrical stimulation, a proportion similar to that for RyR1-expressing myotubes (Fig. 3) . Thus, the R16 region is not necessary for skeletal-type EC coupling or retrograde signaling. To determine whether sR16 is essential for bi-directional signaling, we constructed chimeraR16-rev in which a region of RyR1 that includes sR16 was replaced by RyR2 sequence.
ChimeraR16-rev retained almost normal ability to mediate bi-directional signaling. Thus, it is clear that signaling does not depend upon the presence of RyR1 sequence in the D3 domain, which is highly divergent between RyR1 and RyR2 (32) and is contained in the sR16/cR16
region. The ability of chimeraR16-rev to participate in bi-directional signaling also suggests that the interaction between the s53 and sR16 regions is not the only site of coupling between α 1S and RyR1. However, the ability of chimeraR16-rev to behave almost like RyR1 does not imply that there is no functional role for binding between α 1S and the sR16 region of RyR1 because the cR16 region of RyR2 may also be able to bind to α 1S , as suggested by the yeast two-hybrid experiments (Fig 1) .
The yeast two-hybrid results reinforce previous findings with α 1S chimeras. First, s31
does not bind in two-hybrid experiments to the regions of RyR1 tested here, consistent with observation that bi-directional signaling does not depend on the presence of skeletal sequence in this region (7, 8, 19, 20) . Second, s53 binds to sR16 but c53 does not. This is consistent with observations of chimeric α 1 channels demonstrating that the s53 region is essential for bidirectional signaling (7, 8) and that this signaling is lost when s53 is replaced by c53. Thus, s53 may be one site at which α 1S contacts RyR1 (in the R16 region), consistent with a direct allosteric activation mechanism for coupling between α 1S and RyR1.
It is important to consider limitations of the yeast two-hybrid method, which mean that a failure of interaction cannot be interpreted to mean that the corresponding protein regions do not interact in vivo. First, our use of segments of RyR1 with only a small amount of overlap might have interrupted an interaction motif. More fundamentally, there is an inherent size limitation of segments that can be explored with the two-hybrid method (about 300 residues). These ~300 A number of observations suggest that multiple segments of the primary sequence of both α 1S and RyR1 may be involved in bi-directional signaling. First, Nakai et al. (9) found that two different RyR chimeras were able to support signaling interactions between α 1S and RyR1.
These chimeras contained non-overlapping RyR1 sequence (residues 1635-2636 or 2659-3720) in a background of RyR2. Second, we have shown here that chimeraR16 supports weak signaling, and that stronger signaling is supported by chimeraR16-rev, suggesting that regions of (35) . This may result from a distinct disadvantage of the yeast two-hybrid system, that the size of test fragments is limited to a maximum of about 300 residues and that smaller test fragments appear to reconstitute activity of the GAL4 transcription factor more efficiently than do larger fragments (35) , which is particularly problematic for studies of a protein as large as the RyR. Because it is not possible to screen larger regions of primary sequence for interaction using the two-hybrid system, interaction domains consisting of non-contiguous primary sequence could be missed using the two-hybrid approach. Nonetheless, the method has provided the first identification of a domain that may participate in both direct interaction and functional coupling.
Currently, a scarcity of information about how the primary sequence of RyRs is arranged 
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